Effect of Celecoxib on Transitional Pain After Outpatient Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE4

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sixty adults having shoulder and forearm surgery will receive either placebo or celebrex started preoperatively and continued for 3 days. Rescue medications required as well as pain scores will be assessed using a patient diary to evaluate the effect of celebrex in controlling transitional pain

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Perioperative Pain Control With Celecoxib (Celebrex) in Total Knee Arthroplasty

NCT00598234

Osteoarthritis

COMPLETED PHASE4

Celecoxib in Postoperative Analgesia for Radius Fracture Surgery

NCT05288374

Pain, Postoperative

COMPLETED PHASE4

Does Optimal Control of Pre-operative Chronic and Acute Pain Predict Improved Function After Orthopedic Surgery?

NCT00581685

Osteoarthritis

COMPLETED PHASE3

A Trial Assessing the Outcome of Celecoxib Administration Versus Placebo Following Anterior Cruciate Ligament (ACL) Reconstruction

NCT01186887

Pain

COMPLETED NA

Preemptive Analgesia in Total Knee Arthroplasty

NCT03523832

Acute Pain

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

celebrex

Group Type EXPERIMENTAL

celebrex

Intervention Type DRUG

400 mg celebrex given 1 hour preop and celebrex 200 mg BID postop

2

placebo

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type DRUG

placebo given preop and BID postop

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

celebrex

400 mg celebrex given 1 hour preop and celebrex 200 mg BID postop

Intervention Type DRUG

placebo

placebo given preop and BID postop

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients scheduled for elective ambulatory surgery of the shoulder
* ASA I - III
* Able to read English
* Male or female

Exclusion Criteria

* Allergy to local anesthetic, Cox2, sulpha drug, acetaminophen or oxycodone
* Women who are pregnant or lactating and women of childbearing age and not following acceptable contraceptive precautions
* Any major medical or psychiatric problem
* Those with a known history of narcotic dependence, abuse or chronic narcotic intake
* Patients with known history of peptic ulcer or GI bleeding in the past, ulcers, congestive heart failure, angina or previous heart attack, coagulation problems, venous thrombosis, kidney or liver disease or strokes

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No